Filing Flows

Filing Flows › Medicinova (MNOV) › Who owns the stock

Who owns Medicinova (MNOV) stock

29 funds reported Medicinova (MNOV) shares in their latest 13F filings, worth $7.7M in all. The largest holder is Essex Woodlands Management ($1.5M). Last quarter 7 funds added to their stakes and 11 cut them.

Largest holders of MNOV (13F)Largest holders of MNOV (13F)Essex Woodlands Management$1.5MBlackRock$993KVanguard Group$924KCitigroup$839KVanguard Capital Management LLC$804KGeode Capital Management, LLC$712KVanguard Fiduciary Trust$373KUBS Group AG$293KRenaissance Technologies LLC$271KState Street$256K

Largest holders (13F)

FundSharesValueChangeQuarter
Essex Woodlands Management1,105,941$1.5Munchanged2026-06-30
BlackRock752,091$993Kincrease2026-06-30
Vanguard Group705,625$924Kincrease2025-12-31
Citigroup635,715$839Kunchanged2026-06-30
Vanguard Capital Management LLC609,052$804Kdecrease2026-06-30
Geode Capital Management, LLC539,312$712Kdecrease2026-06-30
Vanguard Fiduciary Trust282,608$373Kincrease2026-06-30
UBS Group AG222,200$293Kunchanged2026-06-30
Renaissance Technologies LLC205,400$271Kincrease2026-06-30
State Street193,698$256Kunchanged2026-06-30
Northern Trust143,665$190Kincrease2026-06-30
Bank of New York Mellon78,277$103Kunchanged2026-06-30
Charles Schwab Investment Management71,506$94Kunchanged2026-06-30
Bridgeway Capital Management, LLC56,031$74Kunchanged2026-06-30
SBI Securities51,479$68Kincrease2026-06-30

Medicinova's latest quarter

Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most MNOV stock?

By the latest 13F filings: Essex Woodlands Management ($1.5M); BlackRock ($993K); Vanguard Group ($924K); Citigroup ($839K); Vanguard Capital Management LLC ($804K).

What is the short interest in MNOV?

292,306 shares were sold short at the 2026-10-15 settlement, -13.8% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.